BMS-817378

CAS No. 1174161-69-3

BMS-817378( BMS817378 )

Catalog No. M10591 CAS No. 1174161-69-3

BMS-817378 is a prodrug of the dual Met/VEGFR-2 inhibitor BMS-794833.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 69 In Stock
10MG 117 In Stock
25MG 188 In Stock
50MG 276 In Stock
100MG 421 In Stock
200MG 607 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BMS-817378
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-817378 is a prodrug of the dual Met/VEGFR-2 inhibitor BMS-794833.
  • Description
    BMS-817378 is a prodrug of the dual Met/VEGFR-2 inhibitor BMS-794833.Solid Tumors Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BMS817378
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    c-Met/HGFR
  • Research Area
    Cancer
  • Indication
    Solid Tumors

Chemical Information

  • CAS Number
    1174161-69-3
  • Formula Weight
    578.85
  • Molecular Formula
    C24H18ClF2N4O7P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC(=CC=C1C2=CN(C=C(C2=O)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F)COP(=O)(O)O)F
  • Chemical Name
    (Z)-N-(4-((3-chloro-2-imino-1,2-dihydropyridin-4-yl)oxy)-3-fluorophenyl)-5-(4-fluorophenyl)-4-oxo-1-((phosphonooxy)methyl)-1,4-dihydropyridine-3-carbimidic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PHA-665752

    PHA-665752 is a potent, selective, ATP-competitive c-Met inhibitor with Ki/IC50 of 4/9 nM.

  • SAR125884

    SAR125844 a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK) for intravenous administration.?(IC50 value of 4.2 nmol/L).

  • MK-8033

    MK-8033 is a potent, specific, dual c-Met/Ron kinases inhibitor with IC50 of 1/7 nM.